Bolt Biotherapeutics Inc
(BOLT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2001 | 09-2001 | 06-2001 | 03-2001 | 12-2000 | |
| Sales | 4,280 | 4,191 | 5,015 | 4,405 | 3,000 |
| Cost of Goods | 2,350 | 2,505 | 2,840 | 2,457 | 1,724 |
| Gross Profit | 1,930 | 1,686 | 2,175 | 1,948 | 1,276 |
| Operating Expenses | 1,554 | 1,640 | 2,109 | 1,847 | 1,898 |
| Operating Income | 726 | 551 | 906 | 558 | 102 |
| Interest Expense | 61 | 71 | 78 | 86 | 97 |
| Other Income | 9 | 11 | 5 | 8 | 9 |
| Pre-tax Income | 674 | 491 | 833 | 480 | 14 |
| Income Tax | 265 | 189 | 428 | 227 | 62 |
| Net Income Continuous | 409 | 302 | 405 | 253 | -48 |
| Net Income | $409 | $302 | $405 | $253 | $-48 |
| EPS Basic Total Ops | 0.05 | 0.04 | 0.05 | 0.03 | -0.01 |
| EPS Basic Continuous Ops | 0.05 | 0.04 | 0.05 | 0.03 | -0.01 |
| EPS Diluted Total Ops | 0.05 | 0.04 | 0.05 | 0.03 | -0.01 |
| EPS Diluted Continuous Ops | 0.05 | 0.04 | 0.05 | 0.03 | -0.01 |
| EBITDA(a) | $802 | $640 | $1,152 | $793 | $339 |